Earnings · China A-shares
Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class A (600671) earnings
Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class A published its Q3 report on 2026-10-30: net profit -42.93% year on year, -83.05% excluding one-off items. Wave Radar's earnings-quality score is 82 of 100 (Sound). The stock moved -0.93% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-30
- Period end
- 2026-09-30
- Net profit YoY
- -42.93%
- Excl. one-offs YoY
- -83.05%
- Net profit QoQ
- -27.44%
- Result
- Bad / loss
- Quality score
- 82
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +2.21% | — |
| 3 days | -0.93% | — |
| 7 days | +0.52% | — |
| 14 days | -16.52% | — |
Report history
Over the last 8 reports, net profit grew year on year in 5 of them. The stock rose in the 3 trading days after 4 of 8 reports (average +0.01%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-31 | ¥8.11M | -42.93% | -83.05% | -5.76% | 0.07 | 10.95% | -0.93% | — | — |
| 2026 interim report | 2026-08-28 | ¥6.30M | -38.50% | -60.68% | -4.10% | 0.05 | 8.61% | +11.49% | +0.50% | +10.19% |
| 2026 Q1 report | 2026-04-30 | ¥3.82M | -25.09% | -38.06% | -15.12% | 0.03 | 5.31% | +0.56% | -17.72% | -19.77% |
| 2025 annual report | 2026-04-18 | ¥17.62M | +15.59% | +35.19% | -2.55% | 0.14 | 28.80% | -2.41% | -12.32% | -17.08% |
| 2025 Q3 report | 2025-10-29 | ¥14.21M | +484.48% | +238.38% | +27.48% | 0.12 | 23.89% | -3.43% | -11.72% | -8.25% |
| 2025 interim report | 2025-08-28 | ¥10.25M | +155.39% | +126.76% | +73.97% | 0.08 | 17.82% | +0.41% | +0.36% | -5.14% |
| 2025 Q1 report | 2025-04-28 | ¥5.09M | +152.40% | +134.02% | +88.55% | 0.04 | 9.27% | -7.84% | -10.03% | -13.28% |
| 2024 annual report | 2025-04-01 | ¥15.25M | +139.83% | +125.55% | +78.44% | 0.13 | 34.06% | +2.26% | +17.46% | +17.39% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.